30 April 2008 Lundbeck expands geographical rights for Circadin®
24 September 2007 Neurim Pharmaceuticals licenses Circadin®, a drug approved for the treatment of primary insomnia, to Lundbeck   06 July 2007 Nycomed to market Circadin® for primary insomnia   29 June 2007 An Authorisation valid throughout the European Union was issued by the EMEA for Circadin®   27 April 2007 Neurim Pharmaceuticals announce that Circadin® (prolonged-release melatonin) for Primary Insomnia is recommended for approval in the EU   26 April 2007 Summary of positive opinion for Circadin® (EMEA Press Release) 06 July 2007 Nycomed to market Circadin® for primary insomnia
29 June 2007 An Authorisation valid throughout the European Union was issued by the EMEA for Circadin®
27 April 2007 Neurim Pharmaceuticals announce that Circadin® (prolonged-release melatonin) for Primary Insomnia is recommended for approval in the EU
26 April 2007 Summary of positive opinion for Circadin® (EMEA Press Release)